About
BIB provides 2x daily exposure to a modified market-cap-weighted index of biotechnology and pharmaceutical companies listed on NASDAQ.
- Name
- ProShares Ultra Nasdaq Biotechnology
- Index tracked
- NASDAQ Biotechnology TR USD
- Type
- Other
- Expense ratio
- 1.19%
- Management fee
- 0.75%
- Dividend policy
- Quarterly
- NAV
- USD 113.898 (09/17/2026)
- Issued units
- 840.00K (09/17/2026)
- Listing date
- Apr 6, 2010
- Sponsor
- ProShares
- Custodian
- JPMorgan Chase Bank, N.A.